| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | $0.5B | — | — | — | — | $0.4B | $0.4B |
| R&D Expense | — | — | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.6B | $0.6B | $0.6B | $0.6B | $0.6B | $0.5B | $0.4B | $0.5B |
| Operating Income | — | — | $1.3B | $1.2B | $1.3B | $1.0B | $0.9B | $0.9B |
| Net Income | $0.9B | $-0.0B | $0.7B | $0.7B | $0.9B | $0.6B | $0.5B | $0.5B |
| EPS (Basic) | $3.33 | $-0.11 | $2.25 | $2.27 | $2.69 | $1.79 | $0.49 | $0.45 |
| EPS (Diluted) | $3.30 | $-0.11 | $2.23 | $2.25 | $2.65 | $1.76 | $0.48 | $0.44 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $19.5B | $17.6B | $19.3B | $19.9B | $19.7B | $18.3B | $17.4B | $16.6B |
| Current Assets | $6.1B | $4.8B | $4.9B | $5.5B | $5.2B | $4.7B | $4.9B | $3.9B |
| Cash & Equivalents | $1.2B | $0.9B | $0.7B | $0.5B | $0.6B | $1.4B | $1.8B | $0.7B |
| Total Liabilities | $14.1B | $11.7B | $15.5B | $16.4B | $16.0B | $14.9B | $14.3B | $13.0B |
| Current Liabilities | $5.5B | $4.8B | $6.2B | $7.0B | $6.0B | $4.4B | $5.6B | $4.1B |
| Stockholders' Equity | $5.4B | $5.9B | $3.8B | $3.5B | $3.6B | $3.3B | $2.9B | $3.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $0.1B | $1.9B | $0.3B | $1.8B | $1.4B | $1.5B | $1.6B |
| Investing Cash Flow | $-0.7B | $5.0B | $-1.1B | $-0.8B | $-1.6B | $-1.2B | $-0.4B | $-0.2B |
| Capital Expenditures | $0.5B | $0.5B | $1.0B | $1.7B | $1.7B | $1.1B | $0.6B | $0.8B |
| Financing Cash Flow | $-0.3B | $-4.8B | $-0.7B | $0.5B | $-0.9B | $-0.6B | $-0.0B | $-1.0B |